大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/06/26 | 1,987 | 2,020 | 1,985 | 2,016 | +34 | +1.7% | 156,000 |
| 2017/06/23 | 1,985 | 1,997 | 1,962 | 1,982 | +2 | +0.1% | 99,500 |
| 2017/06/22 | 1,970 | 1,989 | 1,958 | 1,980 | +14 | +0.7% | 68,000 |
| 2017/06/21 | 1,934 | 1,974 | 1,923 | 1,966 | -7 | -0.4% | 57,400 |
| 2017/06/20 | 1,946 | 1,975 | 1,945 | 1,973 | +27 | +1.4% | 49,900 |
| 2017/06/19 | 1,950 | 1,987 | 1,946 | 1,946 | -4 | -0.2% | 72,600 |
| 2017/06/16 | 1,941 | 1,953 | 1,930 | 1,950 | +11 | +0.6% | 39,700 |
| 2017/06/15 | 1,933 | 1,958 | 1,918 | 1,939 | +24 | +1.3% | 62,300 |
| 2017/06/14 | 1,915 | 1,939 | 1,905 | 1,915 | +3 | +0.2% | 33,700 |
| 2017/06/13 | 1,909 | 1,918 | 1,895 | 1,912 | +4 | +0.2% | 18,200 |
| 2017/06/12 | 1,888 | 1,908 | 1,881 | 1,908 | +26 | +1.4% | 30,300 |
| 2017/06/09 | 1,883 | 1,887 | 1,873 | 1,882 | -1 | -0.1% | 29,000 |
| 2017/06/08 | 1,859 | 1,885 | 1,858 | 1,883 | +24 | +1.3% | 29,700 |
| 2017/06/07 | 1,866 | 1,868 | 1,856 | 1,859 | -7 | -0.4% | 21,400 |
| 2017/06/06 | 1,880 | 1,883 | 1,852 | 1,866 | -12 | -0.6% | 27,100 |
| 2017/06/05 | 1,872 | 1,884 | 1,861 | 1,878 | ±0 | ±0% | 19,000 |
| 2017/06/02 | 1,856 | 1,884 | 1,849 | 1,878 | +25 | +1.3% | 67,000 |
| 2017/06/01 | 1,879 | 1,879 | 1,845 | 1,853 | -12 | -0.6% | 53,500 |
| 2017/05/31 | 1,856 | 1,885 | 1,855 | 1,865 | +2 | +0.1% | 63,000 |
| 2017/05/30 | 1,882 | 1,889 | 1,859 | 1,863 | -16 | -0.9% | 31,000 |
| 2017/05/29 | 1,896 | 1,903 | 1,879 | 1,879 | -17 | -0.9% | 33,700 |
| 2017/05/26 | 1,911 | 1,919 | 1,888 | 1,896 | -20 | -1% | 37,300 |
| 2017/05/25 | 1,938 | 1,943 | 1,916 | 1,916 | -34 | -1.7% | 42,300 |
| 2017/05/24 | 1,922 | 1,950 | 1,918 | 1,950 | +28 | +1.5% | 82,900 |
| 2017/05/23 | 1,928 | 1,939 | 1,919 | 1,922 | +3 | +0.2% | 25,800 |
| 2017/05/22 | 1,950 | 1,984 | 1,916 | 1,919 | +13 | +0.7% | 167,900 |
| 2017/05/19 | 1,875 | 1,908 | 1,867 | 1,906 | +31 | +1.7% | 45,900 |
| 2017/05/18 | 1,865 | 1,887 | 1,838 | 1,875 | -18 | -1% | 36,400 |
| 2017/05/17 | 1,873 | 1,893 | 1,873 | 1,893 | +24 | +1.3% | 41,300 |
| 2017/05/16 | 1,855 | 1,872 | 1,855 | 1,869 | +14 | +0.8% | 29,600 |
| 2017/05/15 | 1,829 | 1,857 | 1,808 | 1,855 | -14 | -0.7% | 75,200 |
| 2017/05/12 | 1,878 | 1,889 | 1,869 | 1,869 | -6 | -0.3% | 26,000 |
| 2017/05/11 | 1,884 | 1,895 | 1,874 | 1,875 | -32 | -1.7% | 40,500 |
| 2017/05/10 | 1,879 | 1,914 | 1,879 | 1,907 | +21 | +1.1% | 53,800 |
| 2017/05/09 | 1,881 | 1,891 | 1,872 | 1,886 | +10 | +0.5% | 31,100 |
| 2017/05/08 | 1,867 | 1,890 | 1,858 | 1,876 | +9 | +0.5% | 34,600 |
| 2017/05/02 | 1,871 | 1,877 | 1,864 | 1,867 | +3 | +0.2% | 19,600 |
| 2017/05/01 | 1,852 | 1,870 | 1,844 | 1,864 | +12 | +0.6% | 28,300 |
| 2017/04/28 | 1,836 | 1,856 | 1,830 | 1,852 | +16 | +0.9% | 45,200 |
| 2017/04/27 | 1,826 | 1,844 | 1,825 | 1,836 | +10 | +0.5% | 18,900 |
| 2017/04/26 | 1,837 | 1,841 | 1,822 | 1,826 | +7 | +0.4% | 15,300 |
| 2017/04/25 | 1,815 | 1,825 | 1,810 | 1,819 | +5 | +0.3% | 27,700 |
| 2017/04/24 | 1,816 | 1,818 | 1,805 | 1,814 | +11 | +0.6% | 27,600 |
| 2017/04/21 | 1,800 | 1,810 | 1,795 | 1,803 | +3 | +0.2% | 27,600 |
| 2017/04/20 | 1,802 | 1,817 | 1,796 | 1,800 | -8 | -0.4% | 39,200 |
| 2017/04/19 | 1,800 | 1,814 | 1,798 | 1,808 | +11 | +0.6% | 40,700 |
| 2017/04/18 | 1,800 | 1,810 | 1,791 | 1,797 | -3 | -0.2% | 29,500 |
| 2017/04/17 | 1,801 | 1,813 | 1,798 | 1,800 | -1 | -0.1% | 24,900 |
| 2017/04/14 | 1,806 | 1,814 | 1,796 | 1,801 | -9 | -0.5% | 38,800 |
| 2017/04/13 | 1,816 | 1,818 | 1,802 | 1,810 | -10 | -0.5% | 30,100 |
1951～
2000
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
